Neuroimaging Evidence for the Deficit Subtype of Schizophrenia

被引:128
|
作者
Voineskos, Aristotle N. [1 ,2 ]
Foussias, George [2 ]
Lerch, Jason [3 ,4 ]
Felsky, Daniel [1 ]
Remington, Gary [2 ]
Rajji, Tarek K. [2 ]
Lobaugh, Nancy [1 ]
Pollock, Bruce G. [2 ]
Mulsant, Benoit H. [2 ]
机构
[1] Univ Toronto, Res Imaging Ctr, Toronto, ON M5S 1A1, Canada
[2] Univ Toronto, Ctr Addict & Mental Hlth, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Hosp Sick Children, Toronto, ON M5S 1A1, Canada
[4] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada
基金
加拿大健康研究院;
关键词
WHITE-MATTER; SUMMER BIRTH; NEGATIVE SYMPTOMS; NONDEFICIT SCHIZOPHRENIA; CORTICAL THICKNESS; INTERSTITIAL-CELLS; CEREBRAL-CORTEX; FIBER TRACTS; MRI DATA; DIFFUSION;
D O I
10.1001/jamapsychiatry.2013.786
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Importance: A major obstacle to the identification of the neurobiological correlates of schizophrenia is the substantial clinical heterogeneity present in this disorder. Dividing schizophrenia into "deficit" and "nondeficit" sub-types may reduce heterogeneity and facilitate identification of neurobiological markers of disease. Objective: To determine whether patients with deficit schizophrenia differ from patients with nondeficit schizophrenia and healthy controls in neuroimaging-based measures of white matter tracts and gray matter morphology. Design: A cross-sectional neuroimaging study of patients with the deficit or nondeficit subtype of schizophrenia and healthy controls. Setting: University hospital. Participants: Seventy-seven patients with schizophrenia and 79 healthy controls. Interventions: All participants were administered the Structured Clinical Interview for DSM-IV-TR Axis I Disorders and the Positive and Negative Syndrome Scale; IQ was measured using the Wechsler Test for Adult Reading; global cognitive impairment was grossly assessed using the Mini-Mental State Examination; comorbid physical illness burden was measured by administration of the Clinical Information Rating Scale-Geriatrics; high-resolution magnetic resonance imaging was performed as part of a multimodal imaging protocol; and deficit status was determined using the proxy scale for the deficit syndrome. Main Outcome Measures: Diffusion-based measures of white matter tracts, cortical thickness, cortical surface area, and volumes of subcortical structures. Results: In both an individually matched approach (18 patients with deficit schizophrenia, 18 patients with nondeficit schizophrenia, and 18 healthy controls) and an unmatched population-based approach (18 patients with deficit schizophrenia, 59 patients with nondeficit schizophrenia, and 79 health controls), the patients with deficit schizophrenia demonstrated disruption of white matter tracts compared with patients with nondeficit schizophrenia and healthy controls at the right inferior longitudinal fasciculus, the right arcuate fasciculus, and the left uncinate fasciculus. These findings were supported in patients with first-episode schizophrenia (n=20) who had a deficit score that was strongly correlated with disruption at these same tracts. In contrast, patients with schizophrenia of either subtype exhibited cortical thickness reductions compared with healthy controls, in near-identical neuroanatomic patterns. Surface areas and subcortical volumes did not differ significantly among the 3 groups. Conclusions and Relevance: The convergence of findings in our individually matched sample, our unmatched overall sample, and our first-episode schizophrenia sample demonstrate (1) white matter tract disruption as a neurobiological feature of the deficit syndrome and (2) reductions in cortical thickness as a common feature of patients with a diagnosis of schizophrenia. When taken with previous results in gray matter, our findings in white matter tracts point to neural circuitry important for socioemotional function as a core neurobiological feature of the deficit subtype of schizophrenia.
引用
收藏
页码:472 / 480
页数:9
相关论文
共 50 条
  • [1] Further Neuroimaging Evidence for the Deficit Subtype of Schizophrenia A Cortical Connectomics Analysis
    Wheeler, Anne L.
    Wessa, Michele
    Szeszko, Philip R.
    Foussias, George
    Chakravarty, M. Mallar
    Lerch, Jason P.
    DeRosse, Pamela
    Remington, Gary
    Mulsant, Benoit H.
    Linke, Julia
    Malhotra, Anil K.
    Voineskos, Aristotle N.
    JAMA PSYCHIATRY, 2015, 72 (05) : 446 - 455
  • [2] Genetic evidence for a distinct subtype of schizophrenia characterized by pervasive cognitive deficit
    Hallmayer, JF
    Kalaydjieva, L
    Badcock, J
    Dragovic, M
    Howell, S
    Michie, PT
    Rock, D
    Vile, D
    Williams, R
    Corder, EH
    Hollingsworth, K
    Jablensky, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 77 (03) : 468 - 476
  • [3] Neurocognitive impairment in the deficit subtype of schizophrenia
    Fervaha, Gagan
    Agid, Ofer
    Foussias, George
    Siddiqui, Ishraq
    Takeuchi, Hiroyoshi
    Remington, Gary
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2016, 266 (05) : 397 - 407
  • [4] Neurocognitive impairment in the deficit subtype of schizophrenia
    Gagan Fervaha
    Ofer Agid
    George Foussias
    Ishraq Siddiqui
    Hiroyoshi Takeuchi
    Gary Remington
    European Archives of Psychiatry and Clinical Neuroscience, 2016, 266 : 397 - 407
  • [5] Kraepelinian subtype and deficit syndrome in chronic schizophrenia
    Nakaya, Makoto
    Ohmori, Kenich
    PSYCHIATRY RESEARCH, 2006, 144 (2-3) : 221 - 225
  • [6] Unravelling immune alterations associated with the deficit schizophrenia subtype
    Samochowiec, J.
    Misiak, B.
    Kucharska-Mazur, J.
    Wron, M.
    EUROPEAN PSYCHIATRY, 2020, 63 : S600 - S601
  • [7] Brain neurodevelopmental markers related to the deficit subtype of schizophrenia
    Takahashi, Tsutomu
    Takayanagi, Yoichiro
    Nishikawa, Yumiko
    Nakamura, Mihoko
    Komori, Yuko
    Furuichi, Atsushi
    Kido, Mikio
    Sasabayashi, Daiki
    Noguchi, Kyo
    Suzuki, Michio
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2017, 266 : 10 - 18
  • [8] Neuroimaging Evidence of Neuroinflammation in Chronic Schizophrenia
    Shenton, Martha
    Kubicki, Marek
    Pasternak, Ofer
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S438 - S438
  • [9] Evidence for a tetrahydrobiopterin deficit in schizophrenia
    Richardson, MA
    Read, LL
    Clelland, CLT
    Reilly, MA
    Chao, HM
    Guynn, RW
    Suckow, RF
    Clelland, JD
    NEUROPSYCHOBIOLOGY, 2005, 52 (04) : 190 - 201
  • [10] Evaluating the evidence for a neuroimaging subtype of posttraumatic stress disorder
    Esterman, Michael
    Stumps, Anna
    Jagger-Rickels, Audreyana
    Rothlein, David
    DeGutis, Joseph
    Fortenbaugh, Francesca
    Romer, Adrienne
    Milberg, William
    Marx, Brian P.
    McGlinchey, Regina
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (568)